Literature DB >> 23681704

Progress in stem cell therapy for major human neurological disorders.

P L Martínez-Morales1, A Revilla, I Ocaña, C González, P Sainz, D McGuire, I Liste.   

Abstract

Human neurological disorders such as Alzheimer's disease (AD), Parkinson's disease, stroke or spinal cord injury are caused by the loss of neurons and glial cells in the brain or spinal cord in the Central Nervous System (CNS). Stem cell technology has become an attractive option to investigate and treat these diseases. Several types of neurons and glial cells have successfully been generated from stem cells, which in some cases, have ameliorated some dysfunctions both in animal models of neurological disorders and in patients at clinical level. Stem cell-based therapies can be beneficial by acting through several mechanisms such as cell replacement, modulation of inflammation and trophic actions. Here we review recent and current remarkable clinical studies involving stem cell-based therapy for AD and stroke and provide an overview of the different types of stem cells available nowadays, their main properties and how they are developing as a possible therapy for neurological disorders.

Entities:  

Mesh:

Year:  2013        PMID: 23681704     DOI: 10.1007/s12015-013-9443-6

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  168 in total

1.  Stem-cell pioneer bows out.

Authors:  Monya Baker
Journal:  Nature       Date:  2011-11-22       Impact factor: 49.962

2.  A dermal niche for multipotent adult skin-derived precursor cells.

Authors:  Karl J L Fernandes; Ian A McKenzie; Pleasantine Mill; Kristen M Smith; Mahnaz Akhavan; Fanie Barnabé-Heider; Jeff Biernaskie; Adrienne Junek; Nao R Kobayashi; Jean G Toma; David R Kaplan; Patricia A Labosky; Victor Rafuse; Chi-Chung Hui; Freda D Miller
Journal:  Nat Cell Biol       Date:  2004-11       Impact factor: 28.824

Review 3.  Neural crest stem and progenitor cells.

Authors:  Jennifer F Crane; Paul A Trainor
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

4.  Analysis of the neurogenic potential of multipotent skin-derived precursors.

Authors:  Karl J L Fernandes; Nao R Kobayashi; Conor J Gallagher; Fanie Barnabé-Heider; Anne Aumont; David R Kaplan; Freda D Miller
Journal:  Exp Neurol       Date:  2006-05-05       Impact factor: 5.330

Review 5.  Intraneuronal trafficking of G-protein-coupled receptors in vivo.

Authors:  Véronique Bernard; Marion Décossas; Isabel Liste; Bertrand Bloch
Journal:  Trends Neurosci       Date:  2006-01-27       Impact factor: 13.837

Review 6.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

7.  Proteomic and phosphoproteomic comparison of human ES and iPS cells.

Authors:  Douglas H Phanstiel; Justin Brumbaugh; Craig D Wenger; Shulan Tian; Mitchell D Probasco; Derek J Bailey; Danielle L Swaney; Mark A Tervo; Jennifer M Bolin; Victor Ruotti; Ron Stewart; James A Thomson; Joshua J Coon
Journal:  Nat Methods       Date:  2011-09-11       Impact factor: 28.547

8.  Clinical observation of fetal olfactory ensheathing glia transplantation (OEGT) in patients with complete chronic spinal cord injury.

Authors:  Jun Wu; Tiansheng Sun; Chaoqun Ye; Jianhua Yao; Bing Zhu; Hongying He
Journal:  Cell Transplant       Date:  2012       Impact factor: 4.064

Review 9.  Stem cell technology for neurodegenerative diseases.

Authors:  J Simon Lunn; Stacey A Sakowski; Junguk Hur; Eva L Feldman
Journal:  Ann Neurol       Date:  2011-09       Impact factor: 10.422

10.  The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.

Authors:  Csaba Nyakas; Ivica Granic; László G Halmy; Pradeep Banerjee; Paul G M Luiten
Journal:  Behav Brain Res       Date:  2010-05-27       Impact factor: 3.332

View more
  35 in total

1.  Defining the optimal window for cranial transplantation of human induced pluripotent stem cell-derived cells to ameliorate radiation-induced cognitive impairment.

Authors:  Munjal M Acharya; Vahan Martirosian; Lori-Ann Christie; Lara Riparip; Jan Strnadel; Vipan K Parihar; Charles L Limoli
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

Review 2.  Stem cell therapies in age-related neurodegenerative diseases and stroke.

Authors:  Yuan Wang; Xunming Ji; Rehana K Leak; Fenghua Chen; Guodong Cao
Journal:  Ageing Res Rev       Date:  2016-11-19       Impact factor: 10.895

3.  Interaction between nonviral reprogrammed fibroblast stem cells and trophic factors for brain repair.

Authors:  G Liu; H Anisman; J Bobyn; S Hayley
Journal:  Mol Neurobiol       Date:  2014-03-28       Impact factor: 5.590

Review 4.  Identifying the role of microRNAs in spinal cord injury.

Authors:  Jun Dong; Meng Lu; Xijing He; Junkui Xu; Jie Qin; Zhijian Cheng; Baobao Liang; Dong Wang; Haopeng Li
Journal:  Neurol Sci       Date:  2014-09-18       Impact factor: 3.307

5.  Fasudil Enhances Therapeutic Efficacy of Neural Stem Cells in the Mouse Model of MPTP-Induced Parkinson's Disease.

Authors:  Yan-Hua Li; Jing-Wen Yu; Jian-Yin Xi; Wen-Bo Yu; Jian-Chun Liu; Qing Wang; Li-Juan Song; Ling Feng; Ya-Ping Yan; Guang-Xian Zhang; Bao-Guo Xiao; Cun-Gen Ma
Journal:  Mol Neurobiol       Date:  2016-09-02       Impact factor: 5.590

Review 6.  In vivo imaging of transplanted stem cells in the central nervous system.

Authors:  Ben A Duffy; Andrew J Weitz; Jin Hyung Lee
Journal:  Curr Opin Genet Dev       Date:  2014-11-05       Impact factor: 5.578

7.  Pericytes modulate myelination in the central nervous system.

Authors:  Patrick O Azevedo; Isadora F G Sena; Julia P Andreotti; Juliana Carvalho-Tavares; José C Alves-Filho; Thiago M Cunha; Fernando Q Cunha; Akiva Mintz; Alexander Birbrair
Journal:  J Cell Physiol       Date:  2018-03-01       Impact factor: 6.384

8.  The change tendency of PI3K/Akt pathway after spinal cord injury.

Authors:  Peixun Zhang; Luping Zhang; Lei Zhu; Fangmin Chen; Shuai Zhou; Ting Tian; Yuqiang Zhang; Xiaorui Jiang; Xuekun Li; Chuansen Zhang; Lin Xu; Fei Huang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

9.  Aβ42 Peptide Promotes Proliferation and Gliogenesis in Human Neural Stem Cells.

Authors:  A Bernabeu-Zornoza; R Coronel; C Palmer; M Calero; A Martínez-Serrano; E Cano; Alberto Zambrano; Isabel Liste
Journal:  Mol Neurobiol       Date:  2018-09-27       Impact factor: 5.590

10.  Stem cell therapy for the treatment of parasitic infections: is it far away?

Authors:  Yan Zhang; Jing-Yi Mi; Yong-Jun Rui; Yong-Liang Xu; Wei Wang
Journal:  Parasitol Res       Date:  2013-11-26       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.